Is Eravacycline Ready for Prime Time Against CRAB Pneumonia?September 22nd 2022
Eravacycline is an antibiotic that has been touted for possible treatment of difficult-to-treat resistant (DTR) Gram-negative infections. But can it tackle carbapenem-resistant Acinetobacter baumannii (CRAB) infections?
Improvement of Long-Term Outcomes of MSSA Bacteremia With Formal Infectious Disease ConsultsMarch 3rd 2020
Staphylococcus aureus is a major cause of both health care-acquired and community-acquired infections ranging from skin and soft tissue infections to more invasive infections like bacteremia
Comparing Effectiveness of Agents for MSSA BacteremiaAugust 16th 2019
Evidence demonstrates that antimicrobial therapy with an anti-staphylococcal β-lactam antibiotic is the gold standard for treatment of SAB caused by MSSA, but confusion about which agent—particularly cefazolin versus an anti-staphylococcal penicillin—is preferred remains an unanswered question